Altered awareness of cognitive and neuropsychiatric symptoms in Parkinson's disease and Dementia with Lewy Bodies: A systematic review

Abstract

Objectives: Altered awareness of cognitive and neuropsychiatric symptoms is a common feature of neurodegeneration, which can significantly impact on quality of life, medication concordance and personal safety. Elucidating how awareness is affected by common alpha-synucleinopathies therefore has significant clinical relevance. We performed a systematic review of the literature on awareness of cognitive and neuropsychiatric symptoms in Parkinson's disease and Dementia with Lewy Bodies. Methods: Searches of PubMed and Web of Science were carried out, using keywords and MeSH subheadings, limited to papers in English dealing with humans. The terms "Parkinson's" or "Lewy body" were used to denote the disease of interest, combined with either "agnosia", "anosognosia", "insight", "metacognition", or "neuropsychology" to denote the neuropsychological area of interest. Results: 21 publications investigating awareness of cognitive symptoms, and 18 publications on awareness of neuropsychiatric symptoms were identified. The large majority focused on Parkinson's disease rather than Dementia with Lewy Bodies. Cognitively intact people with Parkinson's disease may over-report cognitive symptoms, whilst those with cognitive impairment under-report symptoms. Awareness of neuropsychiatric symptoms is likely to decline over time, particularly in those with progressive cognitive impairment. Conclusions: Altered awareness of cognitive and neuropsychiatric symptoms is common in Parkinson's disease. Symptom awareness varies significantly between individuals, and appears to be influenced by mood and global cognitive functioning, with executive functioning specifically implicated. There are gaps in our understanding of how dopaminergic medications influence symptom awareness, and a need for longitudinal studies of how awareness changes over time in Parkinson's disease and Dementia with Lewy Bodies.

Divergence Between Informant and Self-Ratings of Activities of Daily Living Impairments in Parkinson’s Disease

“…When examining non-demented patients, agreement ratings tended to be worse than when examining the entire sample. This is interesting, as anosognosia is not necessarily found in earlier stages of cognitive decline, although reports are varied (Pennington et al, 2021). We also examined associations directly with cognitive domains.…”

Incidence of mental and behavioral disorders due to alcohol use in Tocantins state associated with the COVID-19 pandemic

“…The manifestations described have an impact on the quality of life (QoL) of the patients themselves and their caregivers, as well as on the performance of activities of daily living (ADLs). (ORGETA et al, 2020;PENNINGTON;DUNCAN;RITCHIE, 2020).…”

Antenatal education on the signs of labor an integrative literature review

“…Cognitive symptoms manifest mainly in executive functions, attention and with visuospatial impairments, while dementia manifests in approximately 80% of cases. (MUELLER et al, 2018;PENNINGTON;DUNCAN;RITCHIE, 2020; Chapter 55…”